Target intelligence / Profile preview

DNA guanine N-7 (N7-G)

Target
N7-G
Molecular classification
Nucleic acid, DNA
01

Overview

DNA guanine N-7 refers to the nitrogen atom at the 7th position of the guanine purine ring within the DNA structure. This specific site is the most nucleophilic position in DNA and is highly accessible within the major groove of the double helix, making it a primary target for various electrophilic chemical agents (PubChem, CID 135). In a biological context, the N7 position is involved in maintaining the structural integrity of the genetic code, though it does not participate in Watson-Crick base pairing. In oncology, this site is the principal target for alkylating agents and platinum-based chemotherapies (StatPearls, Alkylating Agents). When drugs like cyclophosphamide or cisplatin bind covalently to the N7 nitrogen, they form DNA adducts and cross-links that obstruct essential cellular processes such as DNA replication and transcription. This interference induces DNA damage responses and leads to programmed cell death (apoptosis) in rapidly proliferating cancer cells (PubMed, PMID 15769544). However, damage to this site can also be mutagenic if not properly repaired by cellular machinery, potentially leading to secondary cancers (NIH, National Cancer Institute). Therapeutic challenges include the development of resistance through enhanced DNA repair mechanisms and the non-specific nature of these drugs, which leads to significant systemic toxicity.

Other names
N7-guanineGuanine N77-guanineN7-GuaN7-alkylguanine site
02

Mechanism of action

Covalent binding (alkylation or platination) to the N7 position of guanine bases, leading to the formation of DNA adducts, inter-strand cross-links, and intra-strand cross-links, which physically obstruct DNA replication and transcription machinery (StatPearls, Alkylating Agents; PubMed, PMID 15769544).

03

Biological functions

Genetic information storageDNA replication templateTranscription template
04

Disease associations

CancerMutagenesis
05

Safety considerations

MyelosuppressionSecondary malignancies (e.g., acute myeloid leukemia)NephrotoxicityOtotoxicityGonadal toxicity and infertilityTeratogenicity
06

Interacting drugs

Cyclophosphamide

13 more in the full profile.

07

Biomarkers

N7-guanine adduct levelsgamma-H2AX (DNA damage marker)MGMT expression (O6-methylguanine-DNA methyltransferase)

Beyond the preview

Go deeper on DNA guanine N-7 (N7-G).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA guanine N-7 (N7-G).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call